Clinical trial
Use of BRASS in Sedated Critically-ill Patients as a Predictable Mortality Factor
NCT03835091 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of BRASS in Sedated Critically-ill Patients as a Predictable Mortality Factor
- Lead sponsor
- CHU de Reims
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 7, 2019
- Completion date
- August 26, 2019
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brainstem response